US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.030 +0.020 (+0.40%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abeona Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Crude Oil Moves Higher; General Motors Earnings Top Views ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Dow Jumps Over 200 Points; US Services PMI Falls In April ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is Affirm (AFRM) Stock Moving Today? ↗
Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores. 
Via InvestorPlace
News headline image
US Stocks Higher; PepsiCo Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink ↗
Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements. 
Via Benzinga
News headline image
Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today? ↗
Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement. 
Via InvestorPlace
News headline image
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? ↗
Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning! 
Via InvestorPlace
News headline image
Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Abeona Therapeutics Provides Regulatory Update on Pz-cel
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023 ↗
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
- FDA completed Pre-License Inspection of Abeona’s Cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal Phase 3 VIITAL™ study - 
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces $50 Million Credit Facility
From Abeona Therapeutics Inc.
Via GlobeNewswire
News headline image
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Abeona Therapeutics Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >